Kaneka Ubiquinol™ will join global innovators at the China International Import Expo (CIIE) 2025, taking place from 5–10 November at the National Exhibition and Convention Center in Shanghai, China.
As the world’s first national-level expo dedicated exclusively to imports, the China International Import Expo (CIIE) provides a vital platform for advancing global collaboration in health innovation, connecting ingredient science with the evolving needs of China’s nutraceutical market. Since its launch in 2018, the event has evolved into one of the most influential gatherings in global commerce, attracting government representatives, industry leaders, and multinational brands from across more than 150 countries.
Mitochondrial health continues to gain momentum across China’s healthy ageing and longevity sectors, and CIIE represents an opportunity for science innovators and brandholders to collaborate in shaping the next generation of evidence-based nutraceuticals.
Showcasing Science-Led Innovation in Health
At this year’s event, Kaneka Ubiquinol™ will feature in the Medical Equipment & Healthcare Products Hall (2.2H) — a hub for global innovation in advanced health and nutritional science. The exhibition brings together leaders in biotechnology, nutraceuticals, and functional ingredients, reflecting the growing focus on evidence-based solutions that support human health and longevity.
For over 45 years, Kaneka Ubiquinol™ has led the field of mitochondrial science, delivering precision-fermented, bioidentical Ubiquinol trusted by brandholders and healthcare innovators worldwide. Backed by more than 100 research studies and produced via a patented yeast-based fermentation process, Kaneka Ubiquinol™ continues to set the benchmark for purity, stability, and bioavailability.
As research continues to reveal the critical role of mitochondrial function in energy, cognitive performance, cardiovascular health, and longevity, Kaneka remains committed to advancing understanding and application of this science in partnership with formulators and healthcare professionals globally.
Driving Collaboration and Connection
According to the World Health Organization, China’s population over 60 is projected to reach 28% by 2040, highlighting the growing demand for solutions that support healthy ageing and energy resilience. Kaneka Ubiquinol™ is uniquely positioned to contribute to this national health agenda through clinically grounded ingredient science and global collaboration.
CIIE provides a valuable opportunity to engage with brandholders, formulators, and industry partners seeking to expand their footprint in the Asia-Pacific region. Through meaningful exchange, Kaneka Ubiquinol™ continues to foster partnerships that drive evidence-based innovation and support sustainable growth across the global nutraceutical landscape.
Visitors are invited to connect with the Kaneka Ubiquinol™ team in the Medical Equipment & Healthcare Products Hall (2.2H), Booth 2-2B4-03, to learn more about how mitochondrial science is powering the new wave of nutraceutical innovation and to explore how partnership with Kaneka can help advance new product development pipelines.
Event Details
📅 5–10 November 2025
📍 National Exhibition and Convention Center (Shanghai), China
🏢 Hall 2.2H – Booth 2-2B4-03
Learn more and register: https://www.ciie.org/ciie/f/visitor/pre-book?locale=en
Kaneka Ubiquinol™ is proud to contribute to this global dialogue, reinforcing its commitment to advancing health, wellbeing, and scientific innovation through collaboration and shared expertise.
